SARS-CoV-2 differs from SARS-CoV in the requirements for receptor expression and proteolytic activation
简介:SARS-CoV-2 differs from SARS-CoV in the requirements for receptor expression and proteolytic activation to trigger cell-cell fusion and is not inhibited by Bromhexine